That study is GARBAGE. 1) way too small a subset of patients. 43 patients 2) the study doesn't show there's any change in stroke. It just mentions that in ANIMAL MODELS there is a reduction in stroke. LMAO. Here's an analysis of real trials. The ace inhibitor trial showed a 30% reduction in stroke in HUMANS and looked at 12000 patients. Invalid Link Removed 3) no change in systolic BP in three weeks? That makes no sense. I wouldn't be shocked if these numbers are just made up. 4) utterly garbage journal. 5) two of the researchers own interest in the company marketing celery seed... lmao. (Doddabele Madhavi, PhD, and Daniel Kagan, PhD, are directors in BioActives LLC, the supplier of the celery extract used in this study. KL Venkatesh Rao, MD, has no financial conflict of interest to declare. Michael T. Murray, ND, is a director in BioMedica LLC and a consultant to Natural Factors Nutritional Products, Inc., companies that sell and distribute BioActives celery extract.)